ImmunoGen

IMGN

IMGN
ImmunoGen Stock Quote
$3.94 -$0.06 -1.4%
Price as of August 6, 2020, 4:30 p.m. EDT View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

Interactive Chart


News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.

All

Market Moves

Earnings



Why ImmunoGen Stock Jumped Today

The biotech stock bounced back quickly from Friday's sell-off, which followed the release of worse-than-expected first-quarter results.